Want to see NNVC full AI Analyst Report?
NanoViricides (NNVC) Ratios
653 Followers
NanoViricides Ratios
NNVC's free cash flow for Q3 2026 was $-1.93M. For the 2026 fiscal year, NNVC's free cash flow was increased by $0.00 and operating cash flow was $-1.93M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.66 | 1.28 | 3.66 | 15.81 | 34.92 |
| Quick Ratio | 2.66 | 1.28 | 3.66 | 15.81 | 34.92 |
| Cash Ratio | 2.35 | 1.19 | 3.53 | 15.25 | 34.07 |
| Solvency Ratio | -6.46 | -6.68 | -5.55 | -3.85 | -17.88 |
| Operating Cash Flow Ratio | -6463307.20 | -6.49 | -4.65 | -10.61 | -14.27 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -62.15 |
| Net Current Asset Value | $ 1.97M | $ 364.19K | $ 3.61M | $ 6.41M | $ 14.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.14 | 1.17 | 1.12 | 1.14 | 1.02 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -150.28 | -8358.32 | -73.85 |
| Interest Coverage Ratio | 0.00 | 0.00 | -170.98 | -9534.61 | -1583.76 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Debt to EBITDA | 0.36 | 0.18 | 0.64 | 1.04 | 1.89 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 98.94% | 98.70% | 97.39% | 96.03% | 99.92% |
| Return on Assets (ROA) | -83.24% | -107.29% | -64.68% | -50.82% | -34.50% |
| Return on Equity (ROE) | -94.65% | -125.93% | -72.35% | -57.77% | -35.12% |
| Return on Capital Employed (ROCE) | -95.66% | -127.59% | -74.29% | -54.65% | -35.15% |
| Return on Invested Capital (ROIC) | -95.66% | -127.59% | -74.29% | -54.65% | -35.01% |
| Return on Tangible Assets | -85.92% | -111.28% | -66.37% | -51.84% | -35.01% |
| Earnings Yield | -29.50% | -44.73% | -37.77% | -64.24% | -37.38% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.62 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -225.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 225.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -381217.31 | -0.56 | -0.53 | -0.49 | -0.51 |
| Free Cash Flow Per Share | -385393.90 | -0.56 | -0.55 | -0.50 | -0.54 |
| Dividend Paid and CapEx Coverage Ratio | -91.27 | -148.84 | -40.34 | -37.37 | -18.16 |
| Capital Expenditure Coverage Ratio | -91.27 | -148.84 | -40.34 | -37.37 | -18.16 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -62.15 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -27927094.01% | -40.33% | -29.47% | -43.54% | -28.66% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.37 | -2.22 | -2.65 | -1.56 | -2.67 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 3.21 | 2.82 | 1.92 | 0.90 | 0.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.00 | -2.48 | -3.39 | -2.30 | -3.49 |
| Price-to-Operating Cash Flow Ratio | -0.00 | -2.50 | -3.48 | -2.36 | -3.68 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | 0.22 | 0.49 | -0.27 | 0.20 |
| Enterprise Value Multiple | -3.22 | -2.25 | -2.29 | -0.67 | -1.05 |
| Enterprise Value | 25.07M | 19.61M | 17.16M | 5.22M | 7.71M |
| EV to EBITDA | -3.22 | -2.25 | -2.29 | -0.67 | -1.05 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.00 | -2.30 | -2.65 | -0.90 | -1.24 |
| EV to Operating Cash Flow | -0.00 | -2.31 | -2.72 | -0.92 | -1.31 |
| Tangible Book Value Per Share | 0.41 | 0.48 | 0.94 | 1.25 | 1.97 |
| Shareholders’ Equity Per Share | 0.43 | 0.50 | 0.97 | 1.28 | 2.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.41 | -0.63 | -0.70 | -0.74 | -0.70 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.99 | 1.00 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.94 | 0.90 | 0.76 | 0.66 | 0.73 |
Currency in USD
